A test to detect respiratory mycobacterial infections quickly.
Lab-on-a-Film Multiplexed Test for Respiratory Mycobacterial Infections
['FUNDING_SBIR_2'] · AKONNI BIOSYSTEMS, INC. · NIH-10904843
This study is working on a new test that quickly tells if someone has a specific lung disease caused by certain bacteria, helping doctors figure out the right treatment faster, especially for patients with ongoing breathing issues.
Quick facts
| Phase | ['FUNDING_SBIR_2'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | AKONNI BIOSYSTEMS, INC. (nih funded) |
| Locations | 1 site (FREDERICK, UNITED STATES) |
| Trial ID | NIH-10904843 on ClinicalTrials.gov |
What this research studies
This research focuses on developing a multiplexed diagnostic test that can rapidly identify nontuberculous mycobacterial lung disease (NTM-LD) and its associated antimicrobial resistance. The approach aims to streamline the diagnostic process, which is currently complicated by similarities between NTM-LD and tuberculosis (TB). By using advanced molecular techniques, the test will help healthcare providers differentiate between these conditions and initiate appropriate treatment more efficiently. This could significantly improve patient outcomes, especially for those with chronic respiratory conditions.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals with chronic obstructive pulmonary disease (COPD) or bronchiectasis who are at risk for nontuberculous mycobacterial lung disease.
Not a fit: Patients without respiratory conditions or those not at risk for nontuberculous mycobacterial infections may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to faster and more accurate diagnoses of respiratory mycobacterial infections, improving treatment outcomes for patients.
How similar studies have performed: Other research has shown success in developing rapid diagnostic tests for similar conditions, indicating a promising avenue for this approach.
Where this research is happening
FREDERICK, UNITED STATES
- AKONNI BIOSYSTEMS, INC. — FREDERICK, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: COONEY, CHRISTOPHER GERARD — AKONNI BIOSYSTEMS, INC.
- Study coordinator: COONEY, CHRISTOPHER GERARD
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Airway infections